Notify me when DEERFIELD MANAGEMENT COMPANY, L.P. files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 149 | $7,800,675,970 | +$1,272,428,110 | -$1,441,130,682 | -$168,702,572 | NUVL, BROOKDALE SR LIVING INC, COGT, PRAX, CNC | 13F-HR | 17 Feb 2026, 16:00 |
| Q3 2025 | 151 | $6,524,910,151 | +$1,431,112,586 | -$1,182,830,675 | +$248,281,911 | NUVL, CNC, MRUS, VTRS, UTHR | 13F-HR | 14 Nov 2025, 16:14 |
| Q2 2025 | 124 | $5,509,809,264 | +$648,867,385 | -$546,431,211 | +$102,436,174 | NUVL, OSCR, VTRS, MRUS, CNC | 13F-HR | 14 Aug 2025, 16:00 |
| Q1 2025 | 122 | $5,044,323,594 | +$657,761,807 | -$493,661,307 | +$164,100,500 | NUVL, VTRS, INTEGRA LIFESCIENCES HLDGS C, NBIX, CNC | 13F-HR | 15 May 2025, 16:00 |
| Q4 2024 | 105 | $5,256,971,191 | +$519,836,670 | -$1,117,085,439 | -$597,248,769 | NUVL, VTRS, INTEGRA LIFESCIENCES HLDGS C, CNC, OSCR | 13F-HR | 14 Feb 2025, 16:00 |
| Q3 2024 | 443 | $6,692,805,831 | +$890,438,075 | -$1,137,255,649 | -$246,817,574 | NUVL, VTRS, CNC, MRUS, OSCR | 13F-HR | 14 Nov 2024, 16:01 |
| Q2 2024 | 433 | $6,010,510,629 | +$1,121,434,751 | -$578,234,911 | +$543,199,840 | NUVL, INSMED INC, VTRS, CNC, INTEGRA LIFESCIENCES HLDGS C | 13F-HR | 14 Aug 2024, 16:30 |
| Q1 2024 | 367 | $5,748,069,894 | +$888,564,956 | -$1,209,207,623 | -$320,642,667 | NUVL, VTRS, CNC, LRMR, BROOKDALE SR LIVING INC | 13F-HR | 15 May 2024, 16:00 |
| Q4 2023 | 222 | $5,415,388,759 | +$582,631,629 | -$688,479,617 | -$105,847,988 | NUVL, GLAUKOS CORP, VTRS, INVITAE CORP, NATERA INC | 13F-HR | 14 Feb 2024, 16:01 |
| Q3 2023 | 88 | $4,538,793,245 | +$651,436,930 | -$732,582,258 | -$81,145,328 | NUVL, GLAUKOS CORP, VTRS, INVITAE CORP, TABULA RASA HEALTHCARE INC | 13F-HR | 14 Nov 2023, 16:01 |
| Q2 2023 | 101 | $4,684,196,241 | +$468,097,591 | -$720,495,120 | -$252,397,529 | NUVL, GLAUKOS CORP, VTRS, AMED, NATERA INC | 13F-HR | 14 Aug 2023, 16:23 |
| Q1 2023 | 106 | $4,485,670,170 | +$727,468,127 | -$906,503,259 | -$179,035,132 | NUVL, GLAUKOS CORP, NBIX, CPRX, NATERA INC | 13F-HR | 15 May 2023, 16:00 |
| Q4 2022 | 104 | $4,830,657,687 | +$1,030,841,459 | -$1,351,472,035 | -$320,630,576 | NUVL, GLAUKOS CORP, INVITAE CORP, NBIX, SAREPTA THERAPEUTICS INC | 13F-HR | 14 Feb 2023, 16:11 |
| Q3 2022 | 126 | $5,005,755,000 | +$932,016,647 | -$1,157,105,364 | -$225,088,717 | NUVL, GLAUKOS CORP, AERIE PHARMACEUTICALS INC, INVITAE CORP, NBIX | 13F-HR | 14 Nov 2022, 16:27 |
| Q2 2022 | 123 | $4,746,335,000 | +$1,030,910,508 | -$307,222,464 | +$723,688,044 | GLAUKOS CORP, NUVL, VTRS, AHCO, NBIX | 13F-HR | 15 Aug 2022, 16:53 |
| Q1 2022 | 118 | $4,437,086,000 | +$743,632,475 | -$485,590,628 | +$258,041,847 | GLAUKOS CORP, NUVL, VTRS, AHCO, INVITAE CORP | 13F-HR | 16 May 2022, 16:50 |
| Q4 2021 | 125 | $4,748,699,000 | +$799,266,793 | -$636,183,302 | +$163,083,491 | NUVL, VTRS, AHCO, GLAUKOS CORP, INVITAE CORP | 13F-HR | 14 Feb 2022, 17:06 |
| Q3 2021 | 132 | $5,112,496,000 | +$1,090,103,228 | -$960,552,403 | +$129,550,825 | NUVL, VTRS, INVITAE CORP, AHCO, CMAX | 13F-HR | 15 Nov 2021, 16:53 |
| Q2 2021 | 143 | $5,629,668,000 | +$2,135,949,945 | -$1,107,514,488 | +$1,028,435,457 | VTRS, OMIC, INVITAE CORP, CMAX, AHCO | 13F-HR | 16 Aug 2021, 16:27 |
| Q1 2021 | 133 | $4,758,345,000 | +$2,336,735,785 | -$2,253,586,257 | +$83,149,528 | INVITAE CORP, VTRS, NEVRO CORP, AERIE PHARMACEUTICALS INC, BRIDGEBIO PHARMA INC | 13F-HR | 17 May 2021, 16:26 |
| Q4 2020 | 129 | $5,059,782,000 | +$2,585,664,753 | -$2,253,157,321 | +$332,507,432 | VTRS, INVITAE CORP, NEVRO CORP, NUVASIVE INC, GRAY | 13F-HR | 16 Feb 2021, 16:23 |
| Q3 2020 | 105 | $4,106,901,000 | +$1,684,626,216 | -$1,259,607,400 | +$425,018,816 | INVITAE CORP, MYL, IMMU, NEVRO CORP, HZNP | Restatement | 30 Dec 2020, 16:23 |
| Q2 2020 | 93 | $3,433,887,000 | +$872,232,665 | -$1,465,607,567 | -$593,374,902 | HORIZON PHARMA INVT LTD, MYL, NEVRO CORP, SDGR, DFPHU | 13F-HR | 14 Aug 2020, 16:39 |
| Q1 2020 | 90 | $3,143,140,000 | +$1,130,158,006 | -$623,107,464 | +$507,050,542 | AHCO, MYL, HZNP, HORIZON PHARMA INVT LTD, NEVRO CORP | 13F-HR | 15 May 2020, 16:13 |
| Q4 2019 | 75 | $3,131,706,000 | +$690,674,148 | -$671,280,895 | +$19,393,253 | HORIZON PHARMA INVT LTD, AHCO, HZNP, MYL, NEVRO CORP | 13F-HR | 14 Feb 2020, 16:03 |
| Q3 2019 | 94 | $2,447,802,000 | +$326,488,796 | -$416,889,536 | -$90,400,740 | HZNP, HORIZON PHARMA INVT LTD, MYL, NEVRO CORP, ORTX | 13F-HR | 14 Nov 2019, 16:05 |
| Q2 2019 | 96 | $2,780,311,000 | +$832,052,013 | -$510,892,702 | +$321,159,311 | HZNP, HORIZON PHARMA INVT LTD, MYL, ORTX, NEVRO CORP | 13F-HR | 14 Aug 2019, 16:06 |
| Q1 2019 | 93 | $2,607,815,000 | +$312,968,806 | -$544,397,819 | -$231,429,013 | HZNP, FIXX, ORTX, HORIZON PHARMA INVT LTD, NEVRO CORP | 13F-HR | 15 May 2019, 16:31 |
| Q4 2018 | 98 | $2,461,050,000 | +$570,312,624 | -$460,044,430 | +$110,268,194 | HZNP, ORTX, FIXX, HORIZON PHARMA INVT LTD, NEVRO CORP | 13F-HR | 14 Feb 2019, 16:05 |
| Q3 2018 | 102 | $2,747,044,000 | +$634,034,013 | -$923,398,518 | -$289,364,505 | HZNP, FIXX, HORIZON PHARMA INVT LTD, NEVRO CORP, AERI | 13F-HR | 14 Nov 2018, 16:15 |
| Q2 2018 | 113 | $2,811,148,000 | +$521,566,713 | -$723,514,430 | -$201,947,717 | MNKKQ, HZNP, FIXX, HORIZON PHARMA INVT LTD, MRTX | 13F-HR | 14 Aug 2018, 16:30 |
| Q1 2018 | 115 | $2,818,382,000 | +$797,798,198 | -$539,917,258 | +$257,880,940 | MNKKQ, MYL, FIXX, HZNP, AVXS | 13F-HR | 15 May 2018, 16:31 |
| Q4 2017 | 97 | $2,534,140,000 | +$653,814,926 | -$453,094,563 | +$200,720,363 | MNKKQ, MYL, HZNP, DXCM, GKOS | 13F-HR | 14 Feb 2018, 16:20 |
| Q3 2017 | 90 | $2,213,322,000 | +$671,806,972 | -$395,654,161 | +$276,152,811 | AVXS, MCK, MYL, HZNP, GKOS | 13F-HR | 13 Nov 2017, 11:38 |
| Q2 2017 | 82 | $1,809,812,000 | +$231,730,436 | -$1,019,182,464 | -$787,452,028 | AVXS, HZNP, NXTM, GILD, HORIZON PHARMA INVT LTD | 13F-HR | 14 Aug 2017, 16:02 |
| Q1 2017 | 105 | $2,575,295,000 | +$529,296,837 | -$689,223,871 | -$159,927,034 | AVXS, HZNP, NXTM, HORIZON PHARMA INVT LTD, GILD | 13F-HR | 15 May 2017, 16:03 |
| Q4 2016 | 101 | $2,413,120,000 | +$646,863,700 | -$217,334,636 | +$429,529,064 | HZNP, NXTM, AVXS, PTLA, GWPH | 13F-HR | 14 Feb 2017, 17:03 |
| Q3 2016 | 90 | $2,150,130,000 | +$232,173,054 | -$976,028,572 | -$743,855,518 | GWPH, PTLA, HZNP, NXTM, AVXS | 13F-HR | 14 Nov 2016, 16:29 |
| Q2 2016 | 106 | $2,544,485,000 | +$500,191,595 | -$460,902,441 | +$39,289,154 | HZNP, NXTM, GWPH, PTLA, AVXS | 13F-HR | 15 Aug 2016, 10:22 |
| Q1 2016 | 105 | $2,332,598,000 | +$745,864,184 | -$404,917,021 | +$340,947,163 | HZNP, MYL, NXTM, HEALTHWAYS INC, HORIZON PHARMA INVT LTD | 13F-HR | 16 May 2016, 16:05 |
| Q4 2015 | 107 | $2,377,446,000 | +$370,034,863 | -$685,984,021 | -$315,949,158 | HZNP, NXTM, DYAX, ADPTQ, GSK | 13F-HR | 16 Feb 2016, 16:01 |
| Q3 2015 | 133 | $2,554,080,000 | +$594,082,519 | -$435,220,911 | +$158,861,608 | HZNP, ALLSCRIPTS HEALTHCARE SOLUTN, NXTM, GSK, AET | 13F-HR | 16 Nov 2015, 16:02 |
| Q2 2015 | 119 | $2,986,705,000 | +$842,822,183 | -$1,127,000,149 | -$284,177,966 | HZNP, ALLSCRIPTS HEALTHCARE SOLUTN, FLML, NXTM, ARRY | 13F-HR | 14 Aug 2015, 16:18 |
| Q1 2015 | 1 | $1,044,000 | $0 | $0 | $0 | CORSICANTO LTD | New Holdings | 14 Aug 2015, 16:16 |
| Q1 2015 | 121 | $3,055,579,000 | +$963,560,002 | -$979,547,056 | -$15,987,054 | ASPX, HZNP, ALLSCRIPTS HEALTHCARE SOLUTN, ABBV, NXTM | 13F-HR | 15 May 2015, 16:02 |
| Q4 2014 | 106 | $2,678,116,000 | +$629,621,749 | -$922,252,815 | -$292,631,066 | AUXL, ASPX, HZNP, AGN, FLML | 13F-HR | 17 Feb 2015, 16:31 |
| Q3 2014 | 121 | $2,463,825,000 | +$764,719,893 | -$481,374,176 | +$283,345,717 | AUXL, DENDREON CORP, AGN, NXTM, FLML | 13F-HR | 14 Nov 2014, 16:33 |
| Q2 2014 | 117 | $2,245,815,000 | +$679,829,137 | -$686,924,950 | -$7,095,813 | DENDREON CORP, AUXL, ITMN, FLML, AGN | 13F-HR | 14 Aug 2014, 16:33 |
| Q1 2014 | 115 | $2,178,289,000 | +$832,295,572 | -$620,818,372 | +$211,477,200 | DENDREON CORP, FLML, AUXL, LH, DRNA | 13F-HR | 15 May 2014, 16:31 |
| Q4 2013 | 98 | $1,773,581,000 | $0 | $0 | $0 | DENDREON CORP, AUXL, QCOR, VOLCANO CORPORATION, ARRY | 13F-HR | 14 Feb 2014, 16:25 |